-
公开(公告)号:WO2018200823A1
公开(公告)日:2018-11-01
申请号:PCT/US2018/029585
申请日:2018-04-26
Applicant: ABBOTT LABORATORIES
Inventor: MCQUISTON, Beth , ROGERS, Justin , DATWYLER, Saul , MARINO, Jaime
IPC: G01N33/68
Abstract: Disclosed herein are methods that aid in the hyperacute diagnosis and evaluation of a human subject that has sustained or may have sustained an injury to the head, such as mild, moderate, severe, or moderate to severe traumatic brain injury (TBI), using an early biomarker, such as ubiquitin carboxy-terminal hydrolase L1 (UCH-L1), glial fibrillary acidic protein (GFAP), or a combination thereof. Also disclosed here are methods that aid in the hyperacute determination of whether a human subject that has sustained an injury or may have sustained to the head would benefit from and thus receive a head computerized tomography (CT) scan based on the levels of UCH-L1. These methods involve detecting changes of levels of an early biomarker, such as ubiquitin carboxy-terminal hydrolase L1 (UCH-L1), glial fibrillary acidic protein (GFAP), or a combination thereof, in samples taken from a human subject at a time point within about 2 hours, such as about 10, 12, or 20 minutes, after the subject has sustained or may have sustained an injury to the head and a second time point about 3 hours to about 6 hours after the first sample is taken.
-
公开(公告)号:WO2018191531A1
公开(公告)日:2018-10-18
申请号:PCT/US2018/027353
申请日:2018-04-12
Applicant: ABBOTT LABORATORIES
Inventor: MCQUISTON, Beth , ROGERS, Justin , DATWYLER, Saul , MARINO, Jaime
IPC: G01N33/68
Abstract: Disclosed herein are methods that aid in the hyperacute diagnosis and evaluation of a human subject that has sustained or may have sustained an injury to the head, such as mild or moderate, severe, or moderate to severe traumatic brain injury (TBI), using an early biomarker, such as ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) glial fibrillary acidic protein (GFAP), or a combination thereof. Also disclosed here are methods that aid in the hyperacute determination of whether a human subject that has sustained an injury or may have sustained to the head would benefit from and thus receive a head computerized tomography (CT) scan based on the levels of UCH-L1. These methods involve detecting levels of early biomarker, such as ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) glial fibrillary acidic protein (GFAP), or a combination thereof, in samples taken from a human subject at a time point within about 2 hours, such as about 10, 12, or 20 minutes, after the subject has sustained or may have sustained an injury to the head.
-
公开(公告)号:WO2018175942A1
公开(公告)日:2018-09-27
申请号:PCT/US2018/024112
申请日:2018-03-23
Applicant: ABBOTT LABORATORIES
Inventor: MCQUISTON, Beth , ROGERS, Justin , DATWYLER, Saul , MARINO, Jaime
IPC: G01N33/68
Abstract: Disclosed herein are methods that aid in the diagnosis and evaluation of a human subject that has sustained or may have sustained an injury to the head, such as mild or moderate to severe traumatic brain injury (TBI), using an early biomarker, ubiquitin carboxy-terminal hydrolase L1 (UCH-L1). Also disclosed here are methods that aid in determining whether a human subject that has sustained an injury or may have sustained to the head would benefit from and thus receive a head computerized tomography (CT) scan based on the levels of UCH-L1. These methods involve detecting levels and changes in levels of UCH-L1 in one or more samples taken from a human subject at time points within 24 hours after the subject has sustained or may have sustained an injury to the head.
-
公开(公告)号:WO2018218169A1
公开(公告)日:2018-11-29
申请号:PCT/US2018/034694
申请日:2018-05-25
Applicant: ABBOTT LABORATORIES
Inventor: MCQUISTON, Beth , ROGERS, Justin , MARINO, Jaime , CHANDRAN, Raj , ZHANG, Tiaming , DATWYLER, Saul
Abstract: Disclosed herein are methods that aid in the determination of whether to perform imaging, such as magnetic resonance imaging (MRI) or computerized tomography (CT) scan, on a human subject that has sustained or may have sustained an injury to the head using an early biomarker, such as ubiquitin carboxy-terminal hydrolase LI (UCH-L1), glial fibrillary acidic protein (GFAP), or a combination thereof. These methods involve detecting levels and changes in levels of UCH-L1 and/or GFAP in samples taken from a human subject at time points within 24 hours after the subject has sustained or may have sustained an injury to the head.
-
公开(公告)号:EP3631465A1
公开(公告)日:2020-04-08
申请号:EP18731687.2
申请日:2018-05-25
Applicant: Abbott Laboratories
Inventor: MCQUISTON, Beth , ROGERS, Justin , MARINO, Jaime , CHANDRAN, Raj , ZHANG, Tiaming , DATWYLER, Saul
-
公开(公告)号:EP3610268A1
公开(公告)日:2020-02-19
申请号:EP18723106.3
申请日:2018-04-12
Applicant: Abbott Laboratories
Inventor: MCQUISTON, Beth , ROGERS, Justin , DATWYLER, Saul , MARINO, Jaime
IPC: G01N33/68
-
公开(公告)号:EP3635407A1
公开(公告)日:2020-04-15
申请号:EP18727084.8
申请日:2018-04-26
Applicant: Abbott Laboratories
Inventor: MCQUISTON, Beth , ROGERS, Justin , DATWYLER, Saul , MARINO, Jaime
IPC: G01N33/68
-
公开(公告)号:EP3602069A1
公开(公告)日:2020-02-05
申请号:EP18716856.2
申请日:2018-03-23
Applicant: Abbott Laboratories
Inventor: MCQUISTON, Beth , ROGERS, Justin , DATWYLER, Saul , MARINO, Jaime
IPC: G01N33/68
-
-
-
-
-
-
-